Search for: "Sanofi-Aventis US LLC" Results 21 - 40 of 84
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Aug 2017, 7:02 am by Fraud Fighters
” The allegations against Mylan were brought to court by pharmaceutical manufacturer Sanofi-Aventis US LLC under a provision of the False Claims Act that permits private qui tam whistleblowers to sue alleged wrongdoers on behalf of the federal government. [read post]
18 Aug 2017, 2:15 pm by Michael Sullivan
The Department of Justice announced the settlement on August 17, 2017, of two qui tam cases pending in the District of Massachusetts, United States, et al. ex rel. sanofi-aventis US LLC v. [read post]
18 Aug 2017, 2:15 pm by Michael Sullivan
The Department of Justice announced the settlement on August 17, 2017, of two qui tam cases pending in the District of Massachusetts, United States, et al. ex rel. sanofi-aventis US LLC v. [read post]
18 Aug 2017, 2:15 pm by Finch McCranie, LLP
The Department of Justice announced the settlement on August 17, 2017, of two qui tam cases pending in the District of Massachusetts, United States, et al. ex rel. sanofi-aventis US LLC v. [read post]
10 Oct 2016, 2:59 pm by Michael Grossman
Because permanent alopecia should have been announced by Sanofi-Aventis since day one, its absence from the label constituted grounds for action. [read post]
26 Jul 2014, 9:14 pm by Mark Summerfield
  Methods of medical treatment came under scrutiny of the US Supreme Court in Mayo Collaborative Services v Prometheus Laboratories, Inc and the Australian High Court in Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd (see High Court Rules Methods of Medical Treatment Patent-Eligible). [read post]
18 Jul 2014, 11:55 am
  Gasguzzlers ‘R Us didn’t get its federal bailout and goes bankrupt. [read post]
14 Mar 2014, 1:02 pm
The individual filed suit in Cook County Circuit Court against Bristol-Myers Squibb Co., Sanofi-Aventis US LLC, Sanofi-Aventis US Inc., and Sanofi-Synthelabo Inc. in a claim of strict product liability, manufacturing defect, negligence, and failure to warn. [read post]
17 Oct 2013, 5:00 am by Bexis
  This one gets less play than the others – perhaps because of how courts sometimes use “communication” to get around it in non-prescription medical product cases (more on that to come), or sometimes because plaintiffs might use the same testimony to claim medical malpractice.But prescriber failure to read can be a powerful tool. [read post]
7 Sep 2012, 3:23 pm by Bexis
a PMA device that restricts the ability of the stomach to expand, used as a last-ditch weight control measure in cases of morbid obesity.Ali involves several preemption issues, and is also good on TwIqbal and the Virginia Consumer Protection Act. [read post]
27 Jun 2012, 9:41 am by Gmlevine
These include cases in which the Panel concludes that the timing of the filing is to delay determination of the dispute [Sanofi-aventis v. [read post]
27 Jun 2012, 9:41 am by Gmlevine
These include cases in which the Panel concludes that the timing of the filing is to delay determination of the dispute [Sanofi-aventis v. [read post]
27 Jun 2012, 9:41 am by Gmlevine
These include cases in which the Panel concludes that the timing of the filing is to delay determination of the dispute [Sanofi-aventis v. [read post]
27 Jun 2012, 9:41 am by Gmlevine
These include cases in which the Panel concludes that the timing of the filing is to delay determination of the dispute [Sanofi-aventis v. [read post]
9 Jun 2012, 5:13 am by Russell Beck
” The former Sanofi-Aventis chemist, Yuan Li, who pled guilty in January to passing trade secrets to a Chinese company was sentenced on May 8, 2012 to 18 months in prison and ordered to pay $131,000 in restitution. [read post]